Litigation finance lets investors fund lawsuits in exchange for a cut of any settlement. It's a genuinely uncorrelated asset class — and a genuinely risky one. Here's how it actually works.
Lawsuits are expensive to fight, and plenty of plaintiffs with genuinely strong cases simply can't afford years of litigation against a well-funded defendant. That gap created an entire industry: litigation finance, where outside investors pay some of the legal costs upfront in exchange for a share of whatever settlement or judgment eventually comes through. It's grown from a niche legal-industry tool into something everyday investors can now access through specialized funds and platforms, and it's one of the few asset classes whose returns genuinely don't move with the stock market.
In a typical deal, a litigation funder reviews a pending lawsuit — usually commercial disputes, patent cases, or mass tort claims rather than someone's individual fender-bender case — and agrees to pay some or all of the legal fees and court costs in exchange for a percentage of the eventual payout, often somewhere between 15% and 50% depending on the case's risk and expected timeline. If the case wins or settles, the funder gets paid from the proceeds. If the case loses, the funder typically gets nothing and can't come after the plaintiff for the money, which is the feature that makes this fundamentally different from a loan.
That "non-recourse" structure is the whole point. It's not debt sitting on anyone's balance sheet, and it's why litigation finance is legally structured as an investment rather than a lending product in most jurisdictions. For everyday investors, direct access to individual case funding is rare and usually restricted to accredited investors, but publicly traded litigation finance companies and certain diversified funds have opened a narrower, more liquid way in.
The single biggest selling point is that litigation outcomes are, for the most part, uncorrelated with the stock market, interest rates, or the broader economy. A patent dispute between two companies doesn't care whether the S&P 500 had a good or bad quarter. For investors trying to build a portfolio that doesn't move in lockstep during a downturn, that lack of correlation is genuinely valuable, in the same category as things like royalty investing or other alternative income streams.
Returns on individual case investments, when they work out, can be significant — some funders target 20% to 30% annualized returns on successful cases, reflecting the real risk of a total loss if the case fails. Diversified funds spreading money across dozens or hundreds of cases smooth out that risk considerably, trading some of the highest-case upside for a more moderate, more predictable blended return, often more modest but still attractive.
The most obvious risk is binary case outcomes: unlike a stock that can decline gradually, an individual litigation investment can go to zero if the case loses outright, with no partial recovery. This is exactly why diversification across many cases matters enormously here, arguably more than in almost any other asset class.
The second major risk is time. Litigation regularly takes years longer than anyone expects, through delays, appeals, and settlement negotiations that drag on. Your money can be tied up for three, five, or more years with genuinely no way to know the exact timeline going in, which makes this a poor fit for money you might need on a specific schedule.
The third risk is liquidity, or the lack of it. Direct case investments generally can't be sold or exited early — you're locked in until resolution. Publicly traded litigation finance companies offer daily liquidity since you're buying shares of a company rather than a single case, but that comes with regular stock market volatility layered on top of the underlying litigation risk, which somewhat undercuts the "uncorrelated" appeal that draws people to this space in the first place.
Elena, a mid-career engineer with a diversified portfolio already covering index funds and some dividend-paying stocks, decided to allocate a small slice — about 3% of her total portfolio, roughly $9,000 — into a diversified litigation finance fund that spread investments across more than 60 active cases. She understood going in that some cases would lose entirely and some would take years to resolve. After four years, the fund reported a blended annualized return of roughly 11%, driven by a handful of strong settlement wins that more than offset several cases that produced no return at all. It wasn't a dramatic windfall, but it behaved almost exactly as advertised: steady, uncorrelated, and slow.
Her colleague Victor took a more concentrated approach, putting $15,000 directly into a single commercial contract dispute through a specialized platform that offered accredited investors direct case access, drawn in by a funder's projection of a 35% return within 18 months if the case settled favorably. Instead, the defendant appealed an early ruling, the case dragged into its fourth year, and it ultimately settled for less than the funder's initial estimate, translating to roughly a 6% total return spread over four years rather than the projected 35% over eighteen months — still positive, but a sharp lesson in how unpredictable individual case timelines and outcomes really are compared to a diversified pool.
The most damaging mistake is treating a single case investment like a normal stock pick, when the actual risk profile is closer to a coin flip with a long, unpredictable wait attached. Concentrating meaningful money into one or two individual cases, rather than a diversified fund, dramatically increases the odds of a complete loss on that slice of your portfolio.
Another common mistake is underestimating how long these investments can take to resolve and putting in money you might need within the next few years. This is patient-capital territory, closer in spirit to private equity than to anything with a predictable exit date.
A third mistake is not reading the fee structure carefully. Some litigation finance funds charge management fees on top of their share of case proceeds, which can meaningfully erode net returns even when the underlying cases perform reasonably well.
Start by deciding whether you even qualify for direct case access, since most individual case investments remain restricted to accredited investors, while publicly traded litigation finance companies and certain funds are open more broadly. If you do invest, favor diversified funds spreading risk across many cases over concentrated single-case bets, especially as a first exposure to the asset class. Size the position small relative to your overall portfolio, treating it as a true alternative allocation rather than a core holding. And go in expecting your money to be tied up for years, not months, so you're never forced to exit early at a bad time.
Litigation finance is a real, legitimate asset class with a genuine diversification benefit, not a gimmick. But it comes with binary case risk, long unpredictable timelines, and limited liquidity that make it a poor fit for anything beyond a small, patient slice of an already diversified portfolio. For investors who understand exactly what they're signing up for, it can be one of the more interesting ways to earn passive income that truly doesn't move with the stock market. For everyone else, it's worth understanding before deciding it's not for you right now.
This article is for general informational purposes and isn't personalized investment advice. Litigation finance investments carry significant risk of loss, including total loss of principal, and may not be suitable for all investors — consult a licensed financial advisor before investing.
Join the newsletter your bank hates and your wallet loves.
No spam. Unsubscribe anytime.